Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Rothweiler

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Translational Oncology|June 10, 2015
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line TherapeuticsStefan Vallo, Martin Michaelis, Florian Rothweiler, et al.
Cells|December 22, 2019
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron ChelationJens-Uwe Vogel, Sophie Schmidt, Daniel Schmidt, et al.
Oncology Letters|November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell linesStefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncotarget|February 18, 2016
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transportMartin Michaelis, Florian Rothweiler, Mario Wurglics, et al.
Plos One|July 27, 2017
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrestNavin Sarin, Florian Engel, Ganna V Kalayda, et al.
Cancers|March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell LinesMartin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
Oncology Letters|June 11, 2017
Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cellsStefan Vallo, Raoul Köpp, Martin Michaelis, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Translational Oncology|June 10, 2015
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line TherapeuticsStefan Vallo, Martin Michaelis, Florian Rothweiler, et al.
Cells|December 22, 2019
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron ChelationJens-Uwe Vogel, Sophie Schmidt, Daniel Schmidt, et al.
Oncology Letters|November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell linesStefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncotarget|February 18, 2016
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transportMartin Michaelis, Florian Rothweiler, Mario Wurglics, et al.
Plos One|July 27, 2017
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrestNavin Sarin, Florian Engel, Ganna V Kalayda, et al.
Cancers|March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell LinesMartin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
Oncology Letters|June 11, 2017
Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cellsStefan Vallo, Raoul Köpp, Martin Michaelis, et al.
Pageof 6